Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAND IN Insulin-001
NCT03277222Phase 2Terminated
- Sponsor
- University of Calgary
- Start
- Nov 2018
- Primary completion
- Apr 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of intranasal insulin in HIV-associated neurocognitive disorders (HAND), sponsored by University of Calgary. Started Nov 2018; status: terminated.
02
Drugs
intranasal insulin
03
Conditions
HIV-associated neurocognitive disorders (HAND)
Beyond the preview
Go deeper on NCT03277222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277222.